Scholarlink

<p>Ginsenoside Rh2 (GRh2), a major active component of red ginseng, exhibits significant neuroprotective effects against glutamate-induced excitotoxicity in differentiated PC12 cells. This study found that GRh2 concentration-dependently reversed the loss of cell viability caused by glutamate. It effectively attenuated key pathological events, including intracellular calcium overload, reactive oxygen species accumulation, and mitochondrial membrane potential collapse. Furthermore, GRh2 enhanced synaptic plasticity, as evidenced by improved neurite morphology and increased levels of the synaptic markers neurogranin and neuromodulin. Mechanistic investigations revealed that GRh2 upregulated vascular endothelial growth factor (VEGF) expression and subsequently activated the PI3K/Akt/mTOR signaling pathway. This activation led to increased expression of synaptic proteins (PSD-95 and synaptophysin), an elevated Bcl-2/Bax ratio. Critically, the specific VEGF inhibitor SU11248 and PI3K inhibitor LY294002 abolished all the protective effects of GRh2, confirming the indispensable role of the VEGF/PI3K/Akt/mTOR axis. These results indicate that GRh2 alleviates glutamate-induced neurotoxicity by activating the VEGF-mediated PI3K/Akt/mTOR pathway, thereby improving mitochondrial function, inhibiting oxidative stress and apoptosis, and promoting synaptic integrity. This work provides novel molecular insights into the neuroprotective mechanism and potential of GRh2.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ginsenoside Rh2 Protects Against Glutamate-Induced Neurotoxicity in PC12 Cells via Activation of the VEGF-mediated PI3K/Akt/mTOR Signaling Pathway

  • 期刊论文

  • 发表日期：

    2026年5月7日

查看全文
  • Chun-Yue Zhang,
  • Chang Liu,
  • Liang-Jing Liu,
  • Jian-Ming Yang,
  • Li-Xia Shen,
  • Zhi-Gang Wu

摘要

Ginsenoside Rh2 (GRh2), a major active component of red ginseng, exhibits significant neuroprotective effects against glutamate-induced excitotoxicity in differentiated PC12 cells. This study found that GRh2 concentration-dependently reversed the loss of cell viability caused by glutamate. It effectively attenuated key pathological events, including intracellular calcium overload, reactive oxygen species accumulation, and mitochondrial membrane potential collapse. Furthermore, GRh2 enhanced synaptic plasticity, as evidenced by improved neurite morphology and increased levels of the synaptic markers neurogranin and neuromodulin. Mechanistic investigations revealed that GRh2 upregulated vascular endothelial growth factor (VEGF) expression and subsequently activated the PI3K/Akt/mTOR signaling pathway. This activation led to increased expression of synaptic proteins (PSD-95 and synaptophysin), an elevated Bcl-2/Bax ratio. Critically, the specific VEGF inhibitor SU11248 and PI3K inhibitor LY294002 abolished all the protective effects of GRh2, confirming the indispensable role of the VEGF/PI3K/Akt/mTOR axis. These results indicate that GRh2 alleviates glutamate-induced neurotoxicity by activating the VEGF-mediated PI3K/Akt/mTOR pathway, thereby improving mitochondrial function, inhibiting oxidative stress and apoptosis, and promoting synaptic integrity. This work provides novel molecular insights into the neuroprotective mechanism and potential of GRh2.